Linda Fletcher

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

Susan Branford, Linda Fletcher, Nicholas C.P. Cross et al. · Blood · 2008 · 389 citations · Full text

Medicine, Biostatistics, Performance Measurement +9

Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis

Linda Fletcher, Jeannette L. Dixon, David M. Purdie et al. · Gastroenterology · 2002 · 287 citations · Full text

Medicine, Genetics, Hematology +14

Screening for Hemochromatosis in Asymptomatic Subjects With or Without a Family History

Lawrie W. Powell, Jeannette L. Dixon, Grant A. Ramm et al. · Archives of Internal Medicine · 2006 · 203 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline

Susan Branford, David T Yeung, Wendy T Parker et al. · Blood · 2014 · 198 citations

Medicine, Hematology, Oncology +8

Steatosis Is a Cofactor in Liver Injury in Hemochromatosis

Elizabeth E. Powell, Azmat Ali, Andrew D. Clouston et al. · Gastroenterology · 2005 · 175 citations · Full text

Medicine, Pathobiology, Pathology +12